eFFECTOR Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
eFFECTOR Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2020 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 40M shares, a 96% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 40M -960M -96% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 40M 0 0% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 1B 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 1B 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 1B 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 40M -960M -96% Dec 31, 2022 10-K 2024-03-26
Q3 2022 1B 0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 1B +610M +156% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 1B Mar 31, 2022 10-Q 2022-05-10
Q4 2021 1B +962M +2555% Dec 31, 2021 10-K 2023-03-08
Q3 2021 1B Sep 30, 2021 10-Q 2021-11-08
Q2 2021 390M Jun 30, 2021 8-K 2021-08-31
Q4 2020 37.7M Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.